Global DNA & RNA Oligonucleotides Market Research Report 2022
SKU ID : QYR-21606738 | Publishing Date : 05-Sep-2022 | No. of pages : 92
Detailed TOC of Global DNA & RNA Oligonucleotides Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 DNA Oligonucleotides
1.2.3 RNA Oligonucleotides
1.3 Market by Application
1.3.1 Global DNA & RNA Oligonucleotides Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global DNA & RNA Oligonucleotides Market Perspective (2017-2028)
2.2 DNA & RNA Oligonucleotides Growth Trends by Region
2.2.1 DNA & RNA Oligonucleotides Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 DNA & RNA Oligonucleotides Historic Market Size by Region (2017-2022)
2.2.3 DNA & RNA Oligonucleotides Forecasted Market Size by Region (2023-2028)
2.3 DNA & RNA Oligonucleotides Market Dynamics
2.3.1 DNA & RNA Oligonucleotides Industry Trends
2.3.2 DNA & RNA Oligonucleotides Market Drivers
2.3.3 DNA & RNA Oligonucleotides Market Challenges
2.3.4 DNA & RNA Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA & RNA Oligonucleotides Players by Revenue
3.1.1 Global Top DNA & RNA Oligonucleotides Players by Revenue (2017-2022)
3.1.2 Global DNA & RNA Oligonucleotides Revenue Market Share by Players (2017-2022)
3.2 Global DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by DNA & RNA Oligonucleotides Revenue
3.4 Global DNA & RNA Oligonucleotides Market Concentration Ratio
3.4.1 Global DNA & RNA Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA & RNA Oligonucleotides Revenue in 2021
3.5 DNA & RNA Oligonucleotides Key Players Head office and Area Served
3.6 Key Players DNA & RNA Oligonucleotides Product Solution and Service
3.7 Date of Enter into DNA & RNA Oligonucleotides Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA & RNA Oligonucleotides Breakdown Data by Type
4.1 Global DNA & RNA Oligonucleotides Historic Market Size by Type (2017-2022)
4.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2023-2028)
5 DNA & RNA Oligonucleotides Breakdown Data by Application
5.1 Global DNA & RNA Oligonucleotides Historic Market Size by Application (2017-2022)
5.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America DNA & RNA Oligonucleotides Market Size (2017-2028)
6.2 North America DNA & RNA Oligonucleotides Market Size by Country (2017-2022)
6.3 North America DNA & RNA Oligonucleotides Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe DNA & RNA Oligonucleotides Market Size (2017-2028)
7.2 Europe DNA & RNA Oligonucleotides Market Size by Country (2017-2022)
7.3 Europe DNA & RNA Oligonucleotides Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size (2017-2028)
8.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Country (2017-2022)
8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America DNA & RNA Oligonucleotides Market Size (2017-2028)
9.2 Latin America DNA & RNA Oligonucleotides Market Size by Country (2017-2022)
9.3 Latin America DNA & RNA Oligonucleotides Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size (2017-2028)
10.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2017-2022)
10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Detail
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Introduction
11.1.4 Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.1.5 Eurofins Scientific Recent Development
11.2 Natera
11.2.1 Natera Company Detail
11.2.2 Natera Business Overview
11.2.3 Natera DNA & RNA Oligonucleotides Introduction
11.2.4 Natera Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.2.5 Natera Recent Development
11.3 BGI
11.3.1 BGI Company Detail
11.3.2 BGI Business Overview
11.3.3 BGI DNA & RNA Oligonucleotides Introduction
11.3.4 BGI Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.3.5 BGI Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina DNA & RNA Oligonucleotides Introduction
11.4.4 Illumina Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.4.5 Illumina Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche DNA & RNA Oligonucleotides Introduction
11.5.4 Roche Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.5.5 Roche Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Detail
11.6.2 LabCorp Business Overview
11.6.3 LabCorp DNA & RNA Oligonucleotides Introduction
11.6.4 LabCorp Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.6.5 LabCorp Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Detail
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics DNA & RNA Oligonucleotides Introduction
11.7.4 Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.7.5 Berry Genomics Recent Development
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Detail
11.8.2 Brooks Life Sciences Business Overview
11.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Introduction
11.8.4 Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.8.5 Brooks Life Sciences Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Detail
11.9.2 Macrogen Business Overview
11.9.3 Macrogen DNA & RNA Oligonucleotides Introduction
11.9.4 Macrogen Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.9.5 Macrogen Recent Development
11.10 Genotypic Technology
11.10.1 Genotypic Technology Company Detail
11.10.2 Genotypic Technology Business Overview
11.10.3 Genotypic Technology DNA & RNA Oligonucleotides Introduction
11.10.4 Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.10.5 Genotypic Technology Recent Development
11.11 Dna Link
11.11.1 Dna Link Company Detail
11.11.2 Dna Link Business Overview
11.11.3 Dna Link DNA & RNA Oligonucleotides Introduction
11.11.4 Dna Link Revenue in DNA & RNA Oligonucleotides Business (2017-2022)
11.11.5 Dna Link Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global DNA & RNA Oligonucleotides Market Research Report 2022
List of TablesTable 1. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of DNA Oligonucleotides
Table 3. Key Players of RNA Oligonucleotides
Table 4. Global DNA & RNA Oligonucleotides Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global DNA & RNA Oligonucleotides Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global DNA & RNA Oligonucleotides Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global DNA & RNA Oligonucleotides Market Share by Region (2017-2022)
Table 8. Global DNA & RNA Oligonucleotides Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global DNA & RNA Oligonucleotides Market Share by Region (2023-2028)
Table 10. DNA & RNA Oligonucleotides Market Trends
Table 11. DNA & RNA Oligonucleotides Market Drivers
Table 12. DNA & RNA Oligonucleotides Market Challenges
Table 13. DNA & RNA Oligonucleotides Market Restraints
Table 14. Global DNA & RNA Oligonucleotides Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global DNA & RNA Oligonucleotides Market Share by Players (2017-2022)
Table 16. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2021)
Table 17. Ranking of Global Top DNA & RNA Oligonucleotides Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by DNA & RNA Oligonucleotides Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players DNA & RNA Oligonucleotides Product Solution and Service
Table 21. Date of Enter into DNA & RNA Oligonucleotides Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global DNA & RNA Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2017-2022)
Table 25. Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2023-2028)
Table 27. Global DNA & RNA Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global DNA & RNA Oligonucleotides Revenue Market Share by Application (2017-2022)
Table 29. Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global DNA & RNA Oligonucleotides Revenue Market Share by Application (2023-2028)
Table 31. North America DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
Table 41. Eurofins Scientific Company Detail
Table 42. Eurofins Scientific Business Overview
Table 43. Eurofins Scientific DNA & RNA Oligonucleotides Product
Table 44. Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 45. Eurofins Scientific Recent Development
Table 46. Natera Company Detail
Table 47. Natera Business Overview
Table 48. Natera DNA & RNA Oligonucleotides Product
Table 49. Natera Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 50. Natera Recent Development
Table 51. BGI Company Detail
Table 52. BGI Business Overview
Table 53. BGI DNA & RNA Oligonucleotides Product
Table 54. BGI Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 55. BGI Recent Development
Table 56. Illumina Company Detail
Table 57. Illumina Business Overview
Table 58. Illumina DNA & RNA Oligonucleotides Product
Table 59. Illumina Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 60. Illumina Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche DNA & RNA Oligonucleotides Product
Table 64. Roche Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 65. Roche Recent Development
Table 66. LabCorp Company Detail
Table 67. LabCorp Business Overview
Table 68. LabCorp DNA & RNA Oligonucleotides Product
Table 69. LabCorp Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 70. LabCorp Recent Development
Table 71. Berry Genomics Company Detail
Table 72. Berry Genomics Business Overview
Table 73. Berry Genomics DNA & RNA Oligonucleotides Product
Table 74. Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 75. Berry Genomics Recent Development
Table 76. Brooks Life Sciences Company Detail
Table 77. Brooks Life Sciences Business Overview
Table 78. Brooks Life Sciences DNA & RNA Oligonucleotides Product
Table 79. Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 80. Brooks Life Sciences Recent Development
Table 81. Macrogen Company Detail
Table 82. Macrogen Business Overview
Table 83. Macrogen DNA & RNA Oligonucleotides Product
Table 84. Macrogen Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 85. Macrogen Recent Development
Table 86. Genotypic Technology Company Detail
Table 87. Genotypic Technology Business Overview
Table 88. Genotypic Technology DNA & RNA Oligonucleotides Product
Table 89. Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 90. Genotypic Technology Recent Development
Table 91. Dna Link Company Detail
Table 92. Dna Link Business Overview
Table 93. Dna Link DNA & RNA OligonucleotidesProduct
Table 94. Dna Link Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million)
Table 95. Dna Link Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global DNA & RNA Oligonucleotides Market Share by Type: 2021 VS 2028
Figure 2. DNA Oligonucleotides Features
Figure 3. RNA Oligonucleotides Features
Figure 4. Global DNA & RNA Oligonucleotides Market Share by Application in 2021 & 2028
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Biopharma Companies Case Studies
Figure 7. Academic & Research Organizations Case Studies
Figure 8. Others Case Studies
Figure 9. DNA & RNA Oligonucleotides Report Years Considered
Figure 10. Global DNA & RNA Oligonucleotides Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global DNA & RNA Oligonucleotides Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global DNA & RNA Oligonucleotides Market Share by Region: 2021 VS 2028
Figure 13. Global DNA & RNA Oligonucleotides Market Share by Players in 2021
Figure 14. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by DNA & RNA Oligonucleotides Revenue in 2021
Figure 16. North America DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America DNA & RNA Oligonucleotides Market Share by Country (2017-2028)
Figure 18. United States DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe DNA & RNA Oligonucleotides Market Share by Country (2017-2028)
Figure 22. Germany DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific DNA & RNA Oligonucleotides Market Share by Region (2017-2028)
Figure 30. China DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America DNA & RNA Oligonucleotides Market Share by Country (2017-2028)
Figure 38. Mexico DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa DNA & RNA Oligonucleotides Market Share by Country (2017-2028)
Figure 42. Turkey DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Eurofins Scientific Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 45. Natera Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 46. BGI Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 47. Illumina Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 48. Roche Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 49. LabCorp Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 50. Berry Genomics Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 51. Brooks Life Sciences Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 52. Macrogen Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 53. Genotypic Technology Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 54. Dna Link Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Keyplayers in Global DNA & RNA Oligonucleotides Market Research Report 2022
Eurofins ScientificNatera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link